Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Yusuke, Kaida"'
Autor:
Masato Karayama, Naoki Inui, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa, Noriyuki Enomoto, Kazuhiro Asada, Koji Nishimoto, Masato Fujii, Takashi Matsui, Shun Matsuura, Dai Hashimoto, Mikio Toyoshima, Masaki Ikeda, Hiroyuki Matsuda, Nao Inami, Yusuke Kaida, Satoshi Funayama, Shintaro Ichikawa, Satoshi Goshima, Takafumi Suda
Publikováno v:
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Immune-related pneumonitis (irP) is one of the most important immune-related adverse events caused by immune checkpoint inhibitors (ICIs). After corticosteroid therapy irP frequently relapses, which can interfere with cancer thera
Externí odkaz:
https://doaj.org/article/bb069103ab2445de9eae9f506ee87ea8
Autor:
Noriyuki Enomoto, Shogo Nakai, Shusuke Yazawa, Yasutaka Mochizuka, Atsuki Fukada, Yuko Tanaka, Hyogo Naoi, Yusuke Inoue, Hideki Yasui, Masato Karayama, Yuzo Suzuki, Hironao Hozumi, Kazuki Furuhashi, Mikio Toyoshima, Masato Kono, Shiro Imokawa, Masato Fujii, Taisuke Akamatsu, Naoki Koshimizu, Koshi Yokomura, Hiroyuki Matsuda, Yusuke Kaida, Yutaro Nakamura, Masahiro Shirai, Kazutaka Mori, Masafumi Masuda, Tomoyuki Fujisawa, Naoki Inui, Hiroaki Sugiura, Hiromitsu Sumikawa, Masashi Kitani, Kazuhiro Tabata, Noriyoshi Ogawa, Takafumi Suda
Publikováno v:
Respiratory Research, Vol 25, Iss 1, Pp 1-14 (2024)
Abstract Background Interstitial pneumonia with autoimmune features (IPAF), which does not meet any of the criteria for connective tissue diseases (CTD), has been attracting an attention in patients with idiopathic interstitial pneumonia (IIP). Howev
Externí odkaz:
https://doaj.org/article/d38798487a204e818e149454dbc5d89e
Autor:
Hiroyuki Matsuda, Yuzo Suzuki, Hironao Hozumi, Masato Karayama, Kazuki Furuhashi, Tomoyuki Fujisawa, Noriyuki Enomoto, Naoki Inui, Takafumi Suda, Dai Hashimoto, Masaki Ikeda, Yusuke Inoue, Mikio Toyoshima, Yusuke Kaida, Hideki Yasui, Kazuhiro Asada, Tomohiro Uto, Masato Fujii, Takashi Matsui, Shun Matsuura, Nao Inami, Satoshi Funayama, Shintaro Ichikawa, Satoshi Goshima
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 7 (2023)
Background There has been no prospective trial for treatment of immune-related pneumonitis (irP) occurred after immune checkpoint inhibitors (ICIs).Methods In this single-arm phase II study, patients with cancer with grade ≥2 irP received oral pred
Externí odkaz:
https://doaj.org/article/87a27195de9d45879814549aca29d5ee
Autor:
Sakuya Ito, Yosuke Nakayama, Goh Kodama, Kanji Ota, Kensei Taguchi, Yusuke Kaida, Sho-ichi Yamagishi, Kei Fukami
Publikováno v:
Renal Replacement Therapy, Vol 7, Iss 1, Pp 1-7 (2021)
Abstract Background Some types of antihypertensive drugs may have pleiotropic effects in patients with chronic kidney disease (CKD). However, whether triple combination therapy with angiotensin II receptor blockers (ARBs), calcium channel blockers (C
Externí odkaz:
https://doaj.org/article/3431b0f383f847698cb1d45549a1a913
Autor:
Yuka Kurokawa, Yusuke Kaida, Takuma Hazama, Yosuke Nakayama, Takaomi Otome, Ryo Shibata, Sakuya Ito, Goh Kodama, Nao Nakamura, Takatoshi Kambe, Tomofumi Moriyama, Akiko Nagata, Aki Minami, Ryotaro Ando, Yoshifumi Wada, Miki Sugiyama, Michiaki Usui, Michio Chiba, Atsuo Moriyama, Atsuko Ohara, Hiroshi Miyazaki, Tatsuyuki Kakuma, Kei Fukami
Publikováno v:
Renal Replacement Therapy, Vol 6, Iss 1, Pp 1-10 (2020)
Abstract Background Etelcalcetide is the first intravenously administered calcimimetic agent used to manage secondary hyperparathyroidism (SHPT) in hemodialysis (HD) patients. We evaluated the safety and efficacy of replacing cinacalcet with etelcalc
Externí odkaz:
https://doaj.org/article/44fc4637fec249aab21820b2c2f391c2
Autor:
Junko Yano, Yusuke Kaida, Yosuke Nakayama, Sakuya Ito, Yuka Kurokawa, Nao Nakamura, Takuma Hazama, Takashi Maeda, Ryuki Hashida, Kyoko Tashiro, Takahiro Inokuchi, Hiroo Matsuse, Kei Fukami
Publikováno v:
Renal Replacement Therapy, Vol 5, Iss 1, Pp 1-6 (2019)
Abstract Background and aim Carnitine deficiency is common and associated with muscle atrophy in hemodialysis (HD) patients. We investigated whether carnitine levels could be an independent predictor for exercise capacity in these patients. Method A
Externí odkaz:
https://doaj.org/article/eac2bde917854560ad959c7a8dc950d4
Autor:
Yusuke Kaida, Takatoshi Kambe, Shintaro Kishimoto, Yusuke Koteda, Kenji Suda, Ryo Yamamoto, Tetsurou Imai, Takuma Hazama, Yoshimi Takamiya, Ryo Shibata, Hidemi Nishida, Seiya Okuda, Kei Fukami
Publikováno v:
Renal Replacement Therapy, Vol 3, Iss 1, Pp 1-6 (2017)
Abstract Background The treatment of Kawasaki disease is controversial when intravenous immunoglobulin therapy fails, although it typically relies on combinations of prednisolone, infliximab, cyclosporine, and plasma exchange therapy. The goal of the
Externí odkaz:
https://doaj.org/article/bf3e01053b684b33ab0230e39e5a87ce
Autor:
Miki Sugiyama, Takuma Hazama, Kaoru Nakano, Kengo Urae, Tomofumi Moriyama, Takuya Ariyoshi, Yuka Kurokawa, Goh Kodama, Yoshifumi Wada, Junko Yano, Yoshihiko Otsubo, Ryuji Iwatani, Yukie Kinoshita, Yusuke Kaida, Makoto Nasu, Ryo Shibata, Kyoko Tashiro, Kei Fukami
Publikováno v:
Nutrients, Vol 13, Iss 6, p 1900 (2021)
L-carnitine (LC) supplementation improves cardiac function in hemodialysis (HD) patients. However, whether reducing LC supplementation affects carnitine kinetics and cardiac function in HD patients treated with LC remains unclear. Fifty-nine HD patie
Externí odkaz:
https://doaj.org/article/c935c1b22cd8430a9c36f78ff506ed2f
Autor:
Tadayasu Togawa, Yosuke Nakayama, Yusuke Kaida, Yuka Kurokawa, Takahiro Tsukimura, Takuma Hazama, Makoto Nasu, Hitoshi Sakuraba, Ryo Shibata, Kei Fukami, Akiko Nagata, Nao Nakamura, Seiji Saito
Publikováno v:
Nephrology Dialysis Transplantation
Fabry disease (FD), an X-linked lysosomal storage disorder caused by a deficiency in alfa-galactosidase A (α-Gal A) activity due to mutations in the GLA gene, has a prevalence of 0-1.69% in patients undergoing haemodialysis; however, its prevalence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfd3960661e44a7b68f0eaa92f6a3abf
http://europepmc.org/articles/PMC8577627
http://europepmc.org/articles/PMC8577627
Autor:
Yoshikazu Inoue, Yasuhiko Yamano, Noriyoshi Ogawa, Shiro Imokawa, Yasuhiro Kondoh, Motoyasu Kato, Yoshio Taguchi, Masafumi Masuda, Noriyuki Enomoto, Hirofumi Chiba, Takafumi Suda, Kazutaka Mori, Hajime Takizawa, Yoshinori Tanino, Yasuhiko Nishioka, Mikio Toyoshima, Naoki Koshimizu, Yutaro Nakamura, Yusuke Kaida, Sakae Homma, Miho Kanai, Takehisa Sano, Hiroshi Mukae, Shinyu Izumi, Hiroyuki Matsuda, Naoki Hamada, Hironao Hozumi, Taisuke Akamatsu, Tomoyuki Fujisawa, Shigeo Muro, Takeshi Saraya, Koshi Yokomura, Naohiko Inase, Hiroshi Ishii, Shinobu Akagawa, Hironori Uruga
Publikováno v:
Thorax. 77:143-153
BackgroundSome patients with idiopathic interstitial pneumonia (IIP) show autoimmune features. Interstitial pneumonia with autoimmune features (IPAF) was recently proposed as a research concept in these patients. However, retrospective studies report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ba1ee46207209101521be6304ad017d
https://doi.org/10.1136/thoraxjnl-2020-216263
https://doi.org/10.1136/thoraxjnl-2020-216263